Evidence map›Paper›PMID 24651762›Full record

ArticlePloS one2014

Activation of 2' 5'-oligoadenylate synthetase by stem loops at the 5'-end of the West Nile virus genome.

Soumya Deo, Trushar R Patel, Edis Dzananovic, Evan P Booy, Khalid Zeid, Kevin McEleney, Stephen E Harding, Sean A McKenna

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Restrictome of Flaviviruses.Virologica Sinica · 2020
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Universal RNAFrontiers in microbiology · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Soumya DeoDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Trushar R PatelDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Edis DzananovicDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Evan P BooyDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Khalid ZeidDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Kevin McEleneyDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada; Manitoba Institute for Materials, University of Manitoba, Winnipeg, Manitoba, Canada.
Stephen E HardingNational Centre for Macromolecular Hydrodynamics, University of Nottingham, Sutton Bonington, United Kingdom.
Sean A McKennaDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
University of Manitoba · CAUniversity of Nottingham · GB

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

West Nile virus (WNV) has a positive sense RNA genome with conserved structural elements in the 5' and 3' -untranslated regions required for polyprotein production. Antiviral immunity to WNV is partially mediated through the production of a cluster of proteins known as the interferon stimulated genes (ISGs). The 2' 5'-oligoadenylate synthetases (OAS) are key ISGs that help to amplify the innate immune response. Upon interaction with viral double stranded RNA, OAS enzymes become activated and enable the host cell to restrict viral propagation. Studies have linked mutations in the OAS1 gene to increased susceptibility to WNV infection, highlighting the importance of OAS1 enzyme. Here we report that the region at the 5'-end of the WNV genome comprising both the 5'-UTR and initial coding region is capable of OAS1 activation in vitro. This region contains three RNA stem loops (SLI, SLII, and SLIII), whose relative contribution to OAS1 binding affinity and activation were investigated using electrophoretic mobility shift assays and enzyme kinetics experiments. Stem loop I, comprising nucleotides 1-73, is dispensable for maximum OAS1 activation, as a construct containing only SLII and SLIII was capable of enzymatic activation. Mutations to the RNA binding site of OAS1 confirmed the specificity of the interaction. The purity, monodispersity and homogeneity of the 5'-end (SLI/II/III) and OAS1 were evaluated using dynamic light scattering and analytical ultra-centrifugation. Solution conformations of both the 5'-end RNA of WNV and OAS1 were then elucidated using small-angle x-ray scattering. In the context of purified components in vitro, these data demonstrate the recognition of conserved secondary structural elements of the WNV genome by a member of the interferon-mediated innate immune response.

Indexed as

Genome, ViralInverted Repeat Sequences2',5'-Oligoadenylate SynthetaseBase SequenceBinding SitesCatalysisEnzyme ActivationHumansModels, MolecularMutationNucleic Acid ConformationPolymorphism, Single NucleotideProtein BindingProtein ConformationRecombinant ProteinsSolutions2',5'-Oligoadenylate SynthetaseRecombinant ProteinsSolutions

Identifiers

PMID24651762
PMCPMC3961380
OpenAlexW2076043800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.